Birdwatch Note
2023-12-02 17:55:23 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
新型コロナワクチンの実験動物がワクチンの毒性によって全滅したというネットの噂は事実として確認されていません。 出典 https://www.cov19-vaccine.mhlw.go.jp/qa/0083.html コロナワクチンの成分は公表されています。 例として下記5項目目など。 https://www.niph.go.jp/h-crisis/archives/351898/ なおxbb対応ワクチンに関してはモデルナではヒトの試験をしていたことに注意が必要です。 出典 https://investors.modernatx.com/news/news-details/2023/Moderna-Clinical-Trial-Data-Confirm-Its-Updated-COVID-19-Vaccine-Generates-Robust-Immune-Response-in-Humans-Against-Widely-Circulating-Variants/default.aspx
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730899230137700457
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1731009180017041632
- noteId - 1731009180017041632
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1701539723769
- tweetId - 1730899230137700457
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 新型コロナワクチンの実験動物がワクチンの毒性によって全滅したというネットの噂は事実として確認されていません。 出典 https://www.cov19-vaccine.mhlw.go.jp/qa/0083.html コロナワクチンの成分は公表されています。 例として下記5項目目など。 https://www.niph.go.jp/h-crisis/archives/351898/ なおxbb対応ワクチンに関してはモデルナではヒトの試験をしていたことに注意が必要です。 出典 https://investors.modernatx.com/news/news-details/2023/Moderna-Clinical-Trial-Data-Confirm-Its-Updated-COVID-19-Vaccine-Generates-Robust-Immune-Response-in-Humans-Against-Widely-Circulating-Variants/default.aspx
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-12-02 17:55:23 UTC (1701539723769) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-03 04:27:56 UTC (1701577676238) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-12-02 18:35:46 -0600 | Rating Details | |
2023-12-02 17:32:35 -0600 | Rating Details | |
2023-12-02 17:27:14 -0600 | Rating Details | |
2023-12-02 16:48:35 -0600 | Rating Details | |
2023-12-02 16:44:00 -0600 | Rating Details | |
2023-12-02 16:25:45 -0600 | Rating Details | |
2023-12-02 16:06:15 -0600 | Rating Details | |
2023-12-02 15:31:54 -0600 | Rating Details | |
2023-12-02 12:37:24 -0600 | Rating Details | |
2023-12-02 12:24:15 -0600 | Rating Details | |
2023-12-02 12:21:40 -0600 | Rating Details | |
2023-12-03 16:58:37 -0600 | Rating Details | |
2023-12-03 06:27:14 -0600 | Rating Details | |
2023-12-03 04:06:23 -0600 | Rating Details | |
2023-12-03 03:12:18 -0600 | Rating Details | |
2023-12-03 02:41:47 -0600 | Rating Details | |
2023-12-03 02:24:13 -0600 | Rating Details | |
2023-12-03 01:39:44 -0600 | Rating Details | |
2023-12-03 01:05:45 -0600 | Rating Details | |
2023-12-03 00:51:25 -0600 | Rating Details | |
2023-12-03 00:05:54 -0600 | Rating Details | |
2023-12-02 23:04:58 -0600 | Rating Details | |
2023-12-02 22:24:52 -0600 | Rating Details | |
2023-12-02 22:16:06 -0600 | Rating Details | |
2023-12-02 21:28:12 -0600 | Rating Details | |
2023-12-02 21:00:42 -0600 | Rating Details | |
2023-12-02 20:56:14 -0600 | Rating Details | |
2023-12-02 20:29:38 -0600 | Rating Details | |
2023-12-02 19:59:51 -0600 | Rating Details | |
2023-12-02 19:46:37 -0600 | Rating Details | |
2023-12-02 19:35:06 -0600 | Rating Details | |
2023-12-04 09:16:23 -0600 | Rating Details | |
2023-12-03 11:37:04 -0600 | Rating Details | |
2023-12-03 04:26:00 -0600 | Rating Details | |
2023-12-03 03:14:34 -0600 | Rating Details | |
2023-12-02 23:38:10 -0600 | Rating Details | |
2023-12-02 22:36:12 -0600 | Rating Details | |
2023-12-02 21:42:00 -0600 | Rating Details | |
2023-12-02 21:28:23 -0600 | Rating Details | |
2023-12-02 20:57:18 -0600 | Rating Details | |
2023-12-02 19:47:10 -0600 | Rating Details | |
2023-12-02 19:43:52 -0600 | Rating Details | |
2023-12-02 19:26:22 -0600 | Rating Details | |
2023-12-02 19:16:02 -0600 | Rating Details | |
2023-12-02 18:57:14 -0600 | Rating Details | |
2023-12-02 18:51:59 -0600 | Rating Details | |
2023-12-02 16:59:06 -0600 | Rating Details | |
2023-12-02 16:43:48 -0600 | Rating Details | |
2023-12-02 16:22:04 -0600 | Rating Details | |
2023-12-02 15:55:25 -0600 | Rating Details | |
2023-12-02 15:54:44 -0600 | Rating Details | |
2023-12-02 15:37:48 -0600 | Rating Details | |
2023-12-02 15:27:13 -0600 | Rating Details | |
2023-12-02 15:18:10 -0600 | Rating Details | |
2023-12-02 15:14:16 -0600 | Rating Details | |
2023-12-02 15:08:47 -0600 | Rating Details | |
2023-12-02 14:14:52 -0600 | Rating Details | |
2023-12-02 13:54:56 -0600 | Rating Details | |
2023-12-02 13:18:56 -0600 | Rating Details | |
2023-12-02 12:38:58 -0600 | Rating Details | |
2023-12-02 12:34:29 -0600 | Rating Details | |
2023-12-03 23:32:12 -0600 | Rating Details | |
2023-12-02 19:39:38 -0600 | Rating Details | |
2023-12-02 19:33:45 -0600 | Rating Details | |
2023-12-02 19:19:06 -0600 | Rating Details | |
2023-12-02 19:10:41 -0600 | Rating Details | |
2023-12-02 18:32:14 -0600 | Rating Details | |
2023-12-02 12:58:21 -0600 | Rating Details | |
2023-12-02 11:57:01 -0600 | Rating Details | |
2024-08-17 07:48:34 -0500 | Rating Details |